Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

961 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma: 7-year follow-up results.
Tobinai K, Ogura M, Itoh K, Kinoshita T, Hotta T, Watanabe T, Morishima Y, Igarashi T, Terauchi T, Ohashi Y; All Collaborators of the IDEC-C2B8 Study Group in Japan. Tobinai K, et al. Among authors: hotta t. Cancer Sci. 2010 Dec;101(12):2579-85. doi: 10.1111/j.1349-7006.2010.01703.x. Cancer Sci. 2010. PMID: 20942866 Free PMC article. Clinical Trial.
Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).
Tsukasaki K, Tobinai K, Shimoyama M, Kozuru M, Uike N, Yamada Y, Tomonaga M, Araki K, Kasai M, Takatsuki K, Tara M, Mikuni C, Hotta T; Lymphoma Study Group of the Japan Clinical Oncology Group. Tsukasaki K, et al. Among authors: hotta t. Int J Hematol. 2003 Feb;77(2):164-70. doi: 10.1007/BF02983215. Int J Hematol. 2003. PMID: 12627852 Clinical Trial.
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Takenaka T, Itoh K, Suzuki T, Utsunomiya A, Matsuda S, Chou T, Sai T, Sano M, Konda S, Ohno T, Mikuni C, Deura K, Yamada T, Mizorogi F, Nagoshi H, Tomonaga M, Hotta T, Kawano K, Tsushita K, Hirano M, Shimoyama M; Lymphoma Study Group of the Japan Clinical Oncology Group. Takenaka T, et al. Among authors: hotta t. Int J Hematol. 2004 Feb;79(2):165-73. doi: 10.1532/ijh97.03115. Int J Hematol. 2004. PMID: 15005346 Clinical Trial.
Clinical trials for malignant lymphoma in Japan.
Tobinai K, Hotta T. Tobinai K, et al. Among authors: hotta t. Jpn J Clin Oncol. 2004 Jul;34(7):369-78. doi: 10.1093/jjco/hyh060. Jpn J Clin Oncol. 2004. PMID: 15342663 Review.
A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002.
Kinoshita T, Hotta T, Tobinai K, Kobayashi T, Ishizuka N, Tomonaga M, Sai T, Ohno Y, Kasai M, Ogura M, Mikuni C, Toki H, Sano M, Masaki Y, Ohtsu T, Matsuno Y, Takenaka T, Shirakawa S, Shimoyama M; Japan Clinical Oncology Group. Kinoshita T, et al. Among authors: hotta t. Int J Hematol. 2004 Nov;80(4):341-50. doi: 10.1532/ijh97.04085. Int J Hematol. 2004. PMID: 15615259 Clinical Trial.
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
Mori M, Kitamura K, Masuda M, Hotta T, Miyazaki T, Miura AB, Mizoguchi H, Shibata A, Saito H, Matsuda T, Masaoka T, Harada M, Niho Y, Takaku F. Mori M, et al. Among authors: hotta t. Int J Hematol. 2005 Apr;81(3):246-54. doi: 10.1532/IJH97.03147. Int J Hematol. 2005. PMID: 15814336 Clinical Trial.
Treatment of T-Cell lymphoma.
Hotta T. Hotta T. Hematology. 2005;10 Suppl 1:193-6. doi: 10.1080/10245330512331390393. Hematology. 2005. PMID: 16188671 Free article. Review.
Phase II study of oral fludarabine phosphate in relapsed indolent B-Cell non-Hodgkin's lymphoma.
Tobinai K, Watanabe T, Ogura M, Morishima Y, Ogawa Y, Ishizawa K, Minami H, Utsunomiya A, Taniwaki M, Terauchi T, Nawano S, Matsusako M, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Hayashi M, Seriu T, Hotta T. Tobinai K, et al. Among authors: hotta t. J Clin Oncol. 2006 Jan 1;24(1):174-80. doi: 10.1200/JCO.2005.03.9313. Epub 2005 Dec 5. J Clin Oncol. 2006. PMID: 16330664 Clinical Trial.
961 results